4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-24-036572
Chief Executive Officer sold 16,519 shares at $9.50 ($156,931)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2024-03-25 | Sale 10b5-1 | −16,519 | $9.50 | $156,931 | 580,202 | D |
| Open-market sales · 16,519 sh · avg $9.50 · $156,931 | |||||||
Loading xslF345X05/ownership.xml…